Medicare Enrolled
Dr. Kanwaljit Gill, MD
Cardiovascular Disease · Palmdale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gill?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gill
Dr. Kanwaljit Gill is a cardiovascular disease specialist in Palmdale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gill performed 6,405 Medicare services across 4,486 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gill received a total of $13,739 from 51 pharmaceutical and/or device companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in CA
$13,739 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,405
Medicare services
Top 13% in CA for cardiovascular disease
4,486
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~337 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,089 | $101 | $175 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
818 | $166 | $406 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
688 | $66 | $125 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
547 | $10 | $20 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
333 | $12 | $60 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
253 | $63 | $123 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
252 | $143 | $305 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
204 | $314 | $400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
188 | $100 | $190 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
166 | $20 | $45 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
137 | $56 | $150 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
136 | $48 | $80 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
119 | $20 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
108 | $125 | $250 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
104 | $1 | $25 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
103 | $404 | $825 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
102 | $43 | $250 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
99 | $24 | $55 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
97 | $69 | $113 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
89 | $21 | $35 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
89 | $780 | $1,184 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
85 | $175 | $340 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
82 | $10 | $20 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
73 | $169 | $400 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
66 | $30 | $105 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
53 | $92 | $150 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
43 | $18 | $40 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
40 | $54 | $225 |
| Cardiac catheterization | 38 | $183 | $460 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
36 | $109 | $210 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
26 | $75 | $160 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
26 | $156 | $283 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
25 | $470 | $900 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
25 | $187 | $345 |
| Programming of single lead implantable defibrillator system Adjustment and testing of the settings for a single-lead implantable cardioverter-defibrillator (ICD) to ensure proper function. |
17 | $72 | $140 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
13 | $118 | $380 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
12 | $101 | $300 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
12 | $91 | $175 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
12 | $144 | $260 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.7% high complexity
11.3% medium
65.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,739
Total received (2018-2024)
Avg $1,963/year across 7 years
Top 23% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
580
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,556 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$183 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,211
2023
$1,858
2022
$2,846
2021
$1,641
2020
$759
2019
$2,321
2018
$2,103
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$229
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$199
ShockWave Medical, Inc
$196
Janssen Pharmaceuticals, Inc
$189
AstraZeneca Pharmaceuticals LP
$148
Boston Scientific Corporation
$106
Amgen Inc.
$97
Alnylam Pharmaceuticals Inc.
$83
PFIZER INC.
$76
Mylan Specialty L.P.
$73
BIOTRONIK INC.
$71
Novartis Pharmaceuticals Corporation
$71
E.R. Squibb & Sons, L.L.C.
$64
SCPHARMACEUTICALS INC.
$61
ABIOMED
$61
United Therapeutics Corporation
$60
Dexcom, Inc.
$55
Actelion Pharmaceuticals US, Inc.
$42
Inari Medical, Inc.
$36
Abbott Laboratories
$26
Philips North America LLC
$24
Bayer Healthcare Pharmaceuticals Inc.
$23
Top 3 companies account for 29.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,314
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,843
BOSTON SCIENTIFIC CORPORATION
$1,652
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,009
Janssen Pharmaceuticals, Inc
$707
ABIOMED
$611
Amgen Inc.
$500
PFIZER INC.
$477
Novartis Pharmaceuticals Corporation
$419
GlaxoSmithKline, LLC.
$411
Bayer HealthCare Pharmaceuticals Inc.
$353
BIOTRONIK INC.
$321
Merck Sharp & Dohme LLC
$312
United Therapeutics Corporation
$289
Boston Scientific Corporation
$225
Abbott Laboratories
$215
E.R. Squibb & Sons, L.L.C.
$205
ShockWave Medical, Inc
$196
Astellas Pharma US Inc
$183
Bayer Healthcare Pharmaceuticals Inc.
$171
Shockwave Medical, Inc
$112
Medtronic Vascular, Inc.
$85
Alnylam Pharmaceuticals Inc.
$83
Mylan Specialty L.P.
$73
Amarin Pharma Inc.
$70
Merck Sharp & Dohme Corporation
$69
Medtronic, Inc.
$66
Esperion Therapeutics, Inc.
$65
Chiesi USA, Inc.
$63
SCPHARMACEUTICALS INC.
$61
Edwards Lifesciences Corporation
$60
Dexcom, Inc.
$55
Akcea Therapeutics, Inc.
$50
PORTOLA PHARMACEUTICALS, INC.
$43
Actelion Pharmaceuticals US, Inc.
$42
SANOFI-AVENTIS U.S. LLC
$36
Inari Medical, Inc.
$36
Lundbeck LLC
$34
Regeneron Healthcare Solutions, Inc.
$24
Philips North America LLC
$24
Gilead Sciences, Inc.
$22
Lexicon Pharmaceuticals, Inc.
$21
Arrow International, Inc.
$19
Avinger Inc.
$19
HeartFlow, Inc.
$16
Allergan, Inc.
$16
Biohaven Pharmaceuticals, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$14
Cardinal Health 200, LLC
$13
Relypsa, Inc.
$11
Cardiovascular Systems Inc.
$9
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
(BQ9) Coronary IVUS · AMVIA EDGE · ANDEXXA · ANORO · ANORO ELLIPTA · AVEIR · Adempas · Attain · Azure · BELSOMRA · BEVESPI AEROSPHERE · BRILINTA · Bidil · CAMZYOS · CHANTIX · CONFIRM RX · Catheter - Specialty Access · Corlanor · DALVANCE · Dexcom G6 Transmitter · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL - THERAPIES · General - Therapies · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · INVOKANA · Impella · Inpefa · JANUVIA · JARDIANCE · JOT DX · KENGREAL · Kerendia · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · Micra · NEXLETOL · NORTHERA · NURTEC ODT · ONPATTRO · ORENITRAM · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RESONATE · REVEAL LINQ · Repatha · Reveal LINQ · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · Selectra · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRELEGY ELLIPTA · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Veltassa · Verquvo · VersaCross Access Solution · WAINUA · WATCHMAN Access System · WINREVAIR · XARELTO · YUPELRI · Zero Gravity
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
17
Per 100K population
0.2
County median income
$87,760
Nearest hospital
ANTELOPE VALLEY HOSPITAL
9.8 mi
9.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gill is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gill experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gill performed 1,089 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gill receive payments from pharmaceutical companies?
Yes. Dr. Gill received a total of $13,739 from 51 companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gill's costs compare to other cardiologists in Palmdale?
Dr. Gill's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Palmdale
Browse cardiologists in Palmdale ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology